IQV Q3 2024 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena

IQVIQVIA Holdings Inc.

$30B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.9B+4.3% YoY

Gross Profit

$1.4B35.4% margin

Operating Income

$550M14.1% margin

Net Income

$285M7.3% margin

EPS (Diluted)

$1.55

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$721M

Free Cash Flow

$571M

Stock-Based Comp.

$54M

Balance Sheet

Total Assets

$27.2B

Total Liabilities

$20.2B

Stockholders' Equity

$7.0B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.9B	$3.7B	+4.3%
Gross Profit	$1.4B	$1.3B	+5.2%
Operating Income	$550M	$481M	+14.3%
Net Income	$285M	$303M	-5.9%

Revenue Segments

Research And Development Solutions

$2.2B55%

Technology And Analytics Solutions

$1.6B40%

Contract Sales And Medical Solutions

$180M5%

Geographic Segments

Americas

$1.8B47%

EMEA

$1.3B33%

Asia Pacific

$771M20%